Neftaly Health and Wellness Services

NeftalyApp COURSES Partner INVEST Corporate CHARITY Divisions

[Contact SayPro] [About SayPro][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material] [ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships] [Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Tag: Screening

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Written by

Mapaseka Matabane

in

  • Neftaly Screening for Anemia in Pregnancy

    Neftaly Screening for Anemia in Pregnancy

    Neftaly Screening for Anemia in Pregnancy

    Ensuring Healthy Moms and Babies Through Early Detection

    Anemia during pregnancy is a common yet serious condition that can affect the health of both the mother and the developing baby. At Neftaly, we provide a comprehensive screening program designed to detect anemia early, enabling timely intervention and better pregnancy outcomes.

    What is Anemia in Pregnancy?

    Anemia occurs when the body has fewer red blood cells or less hemoglobin than normal, leading to reduced oxygen delivery to tissues. During pregnancy, anemia can increase risks such as fatigue, preterm birth, low birth weight, and complications during delivery.

    Why is Screening Important?

    • Early Detection: Identifies anemia before symptoms appear.
    • Prevent Complications: Helps prevent risks to mother and baby.
    • Tailored Care: Enables healthcare providers to create effective treatment plans.

    How Neftaly Screening Works

    • Simple Blood Test: A quick, minimally invasive blood sample is taken.
    • Accurate Results: Using advanced laboratory methods, we assess hemoglobin and iron levels.
    • Professional Consultation: Results are reviewed by specialists who guide next steps.
    • Follow-Up Support: Continuous monitoring and care advice throughout pregnancy.

    Who Should Get Screened?

    All pregnant women, ideally during the first prenatal visit and periodically throughout pregnancy, especially those with:

    • History of anemia or nutritional deficiencies
    • Multiple pregnancies or short intervals between pregnancies
    • Symptoms like fatigue, dizziness, or pale skin

    Benefits of Neftaly Screening

    • Convenient and reliable testing
    • Expert interpretation and personalized recommendations
    • Enhanced peace of mind for expectant mothers and families

    Take charge of your pregnancy health today with Neftaly Screening for Anemia. Early detection means better care, healthier moms, and stronger babies.

  • Neftaly Screening for Diabetes Mellitus

    Neftaly Screening for Diabetes Mellitus

    Neftaly Screening for Diabetes Mellitus

    Overview

    Diabetes Mellitus is one of the fastest-growing global health challenges of the 21st century, often going undiagnosed until complications arise. At Neftaly, we believe early detection saves lives. Our Screening for Diabetes Mellitus Program is designed to identify individuals at risk or in the early stages of diabetes through accessible, community-based, and evidence-driven screening initiatives.

    Through widespread awareness, routine testing, and integration with health systems, Neftaly is committed to reducing the burden of diabetes and empowering individuals to take control of their health.

    What is Diabetes Mellitus?

    Diabetes Mellitus is a chronic metabolic condition characterized by high blood sugar levels due to the body’s inability to produce or effectively use insulin. The most common types include:

    • Type 1 Diabetes – An autoimmune condition, often diagnosed in children and young adults.
    • Type 2 Diabetes – Linked to lifestyle factors, often preventable or manageable with early detection.
    • Gestational Diabetes – Occurs during pregnancy and increases the risk of developing Type 2 diabetes later in life.

    Why Screening Matters

    • 1 in 2 people with diabetes are undiagnosed.
    • Early screening can prevent or delay complications such as heart disease, kidney failure, blindness, and limb amputations.
    • Type 2 diabetes can often be reversed or controlled with early lifestyle changes.
    • Screening promotes awareness, lifestyle change, and informed healthcare decisions.

    Neftaly Screening Objectives

    • Identify individuals at risk of developing diabetes or already living with undiagnosed diabetes.
    • Facilitate early intervention and linkage to appropriate care.
    • Educate communities about risk factors, prevention, and healthy living.
    • Support health systems with data, training, and screening tools.
    • Reduce complications and healthcare costs through early detection.

    Target Populations for Screening

    Neftaly prioritizes screening for the following high-risk groups:

    • Adults aged 40 and older
    • Individuals with a family history of diabetes
    • People with high blood pressure, obesity, or sedentary lifestyles
    • Women with a history of gestational diabetes
    • Children and adolescents who are overweight and have additional risk factors

    Screening Methods and Tools

    Our screening process uses both non-invasive and diagnostic methods, including:

    • Risk assessment questionnaires
    • Random blood sugar (RBS) testing
    • Fasting blood glucose (FBG)
    • HbA1c testing for long-term glucose control
    • BMI and waist circumference measurements
    • Referral to healthcare providers for confirmatory testing and management

    All procedures are aligned with WHO and national diabetes screening guidelines.

    Integrated Care and Follow-Up

    Screening is just the first step. Neftaly ensures:

    • Immediate referral pathways for individuals with abnormal results.
    • Access to diabetes education, nutrition counselling, and lifestyle coaching.
    • Ongoing monitoring and community support programs.
    • Collaboration with clinics and health departments to ensure continuity of care.

    Community-Based Outreach

    Neftaly takes screening beyond clinic walls. Our outreach includes:

    • Mobile screening units in underserved areas
    • Workplace and school-based wellness programs
    • Health fairs and public events
    • Digital campaigns and self-assessment tools

    Training for Healthcare Providers

    To ensure quality and consistency, Neftaly provides:

    • Capacity building for nurses, community health workers, and clinicians
    • Screening protocols and decision-making algorithms
    • Patient education materials to support communication and counselling

    Program Impact Goals

    By scaling up diabetes screening, Neftaly aims to:

    • Increase early detection rates by 40% in target communities.
    • Reduce diabetes-related complications and hospitalizations.
    • Empower individuals through education and prevention.
    • Strengthen health system readiness for chronic disease management.

    Partner with Neftaly

    We invite governments, NGOs, clinics, employers, and community organizations to join us in the fight against diabetes. Together, we can:

    • Expand screening access
    • Educate communities
    • Build healthier futures

    ???? Visit www.saypro.org/diabetes-screening or contact us to start a partnership or host a screening event.

    Conclusion

    Diabetes doesn’t have to be a silent killer. Through proactive, inclusive, and informed screening efforts, Neftaly is making early detection possible — one person, one community at a time.

  • Neftaly Screening for Hypertension in Adults

    Neftaly Screening for Hypertension in Adults

    Neftaly Screening for Hypertension in Adults

    Overview:

    Neftaly Screening for Hypertension is a comprehensive, evidence-based tool designed to help healthcare providers identify elevated blood pressure early in adult patients. Early detection through systematic screening enables timely intervention, reducing the risk of cardiovascular disease, stroke, and other hypertension-related complications.

    Why Screen for Hypertension?

    Hypertension is a leading risk factor for heart disease, stroke, kidney failure, and premature death worldwide. Many adults with high blood pressure remain undiagnosed due to the often silent nature of the condition. Routine screening is essential to:

    • Detect elevated blood pressure before symptoms develop.
    • Initiate lifestyle modifications or treatment to prevent progression.
    • Reduce long-term morbidity and healthcare costs.
    • Improve overall population health outcomes.

    Features of Neftaly Hypertension Screening:

    • Standardized Measurement Protocols: Ensures accurate and consistent blood pressure measurement in clinical and community settings.
    • Risk Factor Assessment: Collects information on age, family history, lifestyle, and comorbidities to stratify patient risk.
    • Automated Alerts: Flags patients with readings indicating prehypertension or hypertension for further evaluation.
    • Patient Education: Provides tailored counseling on lifestyle changes such as diet, exercise, and smoking cessation.
    • Follow-up Recommendations: Suggests appropriate intervals for repeat screening or referral based on current clinical guidelines.

    Screening Process:

    1. Patient Preparation: Educate patients on the importance of screening and proper positioning.
    2. Measurement: Use validated devices to measure blood pressure, following best practices (e.g., multiple readings, correct cuff size).
    3. Documentation: Record results promptly and accurately in the patient’s health record.
    4. Interpretation: Compare readings against established thresholds to identify normal, elevated, or hypertensive ranges.
    5. Action Plan: Provide counseling, schedule follow-up assessments, or refer for specialist care as needed.

    Target Population:

    • Adults aged 18 years and older.
    • Individuals with risk factors such as obesity, diabetes, family history of hypertension, or sedentary lifestyle.
    • Populations with limited access to regular healthcare.

    Benefits of Using Neftaly for Hypertension Screening:

    • Promotes early identification and intervention.
    • Supports adherence to national and international hypertension guidelines.
    • Improves patient engagement through education and shared decision-making.
    • Enables data tracking for quality improvement initiatives.

    Conclusion:

    Neftaly Screening for Hypertension in Adults is a vital tool for clinicians aiming to reduce the burden of hypertension-related disease. By facilitating accurate detection and proactive management, Neftaly helps improve cardiovascular health outcomes for individuals and communities.

  • Neftaly Screening for Childhood Obesity

    Neftaly Screening for Childhood Obesity

    You said:

    write content for Neftaly Screening for Childhood Obesity

    ChatGPT said:

    Certainly! Here’s a professional and informative content draft for Neftaly Screening for Childhood Obesity:

    Neftaly Screening for Childhood Obesity

    Early Detection, Effective Intervention

    Childhood obesity is a growing global health concern with significant physical, emotional, and social consequences. At Neftaly, we are dedicated to providing comprehensive screening services to identify and address childhood obesity early, ensuring healthier futures for children.

    Why Screen for Childhood Obesity?

    • Prevent Long-term Health Risks: Childhood obesity increases the risk of developing diabetes, heart disease, hypertension, and other chronic illnesses later in life.
    • Support Emotional Well-being: Excess weight can impact a child’s self-esteem and social interactions.
    • Encourage Healthy Habits: Early detection allows for timely intervention through nutrition, physical activity, and lifestyle changes.

    What is Neftaly Screening?

    Neftaly Screening is a thorough, evidence-based evaluation process designed to identify children at risk of obesity through:

    • Anthropometric Measurements: Height, weight, BMI, and waist circumference to assess body composition.
    • Lifestyle Assessment: Review of dietary habits, physical activity levels, and sedentary behaviors.
    • Medical and Family History: Identifying genetic and environmental risk factors.
    • Psychosocial Screening: Assessing emotional well-being and possible barriers to healthy habits.

    How Neftaly Screening Benefits Your Child

    • Personalized Health Insights: Receive a detailed report highlighting areas of concern and actionable recommendations.
    • Early Intervention Plans: Work with healthcare providers to create tailored nutrition and fitness programs.
    • Ongoing Monitoring: Track progress with follow-up screenings to ensure sustained healthy growth and development.
    • Empowerment for Families: Equip parents and caregivers with tools and knowledge to support their child’s health journey.

    Who Should Consider Neftaly Screening?

    • Children aged 2 to 18 years old
    • Children with rapid weight gain or family history of obesity-related conditions
    • Children experiencing physical or emotional difficulties related to weight

    Protect Your Child’s Health Today

    Contact Neftaly to schedule a childhood obesity screening and take the first step towards a healthier, happier childhood.

  • Neftaly Preventive Screening for Heart Disease

    Neftaly Preventive Screening for Heart Disease

    Neftaly Preventive Screening for Heart Disease – Overview

    Purpose:
    To identify early risk factors for cardiovascular disease (CVD) in asymptomatic individuals, helping prevent heart attacks, strokes, and related conditions.

    ✅ Common Screening Tests Included

    1. Blood Pressure Measurement
      • Detects hypertension (a major heart disease risk factor).
    2. Cholesterol Panel (Lipid Profile)
      • Measures total cholesterol, LDL, HDL, and triglycerides.
    3. Blood Glucose or HbA1c
      • Screens for diabetes or prediabetes, which increases heart disease risk.
    4. Body Mass Index (BMI) and Waist Circumference
      • Assesses overweight/obesity risk.
    5. Electrocardiogram (ECG or EKG)
      • Detects abnormal heart rhythms or previous silent heart attacks.
    6. C-reactive protein (CRP)
      • A marker of inflammation; elevated levels can signal higher cardiovascular risk.
    7. Family History and Lifestyle Assessment
      • Evaluates non-modifiable and behavioral risk factors (diet, smoking, exercise, stress).

    ???? Who Should Get Screened?

    • Adults over age 40
    • Younger adults with:
      • Family history of heart disease
      • High blood pressure or chole
  • Neftaly Prostate Health Screening Guidelines

    Neftaly Prostate Health Screening Guidelines

    commendations:

    1. Only screen informed, asymptomatic men with a life expectancy greater than 10 years (shared decision-making is essential) Journals.co.za.
    2. Do not screen:
      • Men over 70 years old, unless they’re in excellent health and fully informed (screening may still be considered) Journals.co.za.
      • Men with life expectancy under 10 years Journals.co.za.
    3. PSA blood test is the first-line screening tool. Digital rectal exams (DREs) are not recommended routinely for asymptomatic men due to lack of added benefit Journals.co.za.
    4. High-risk groups should begin screening earlier:
      • All men from age 50.
      • Black African men and those with a family history (prostate or breast cancer in a first-degree relative), from age 45.
      • Men with BRCA1/2, HOXB13, ATM, or CHEK2 gene mutations should start at 40, or 10 years younger than the youngest affected relative Journals.co.za.
    5. Screening intervals should be individualized—some guidelines allow up to 8 years between tests, but more frequent testing may be justified in Black African men due to higher risk Journals.co.za.
    6. Pause screening if recent events may raise PSA temporarily:
      • Acute prostatitis, urinary retention, urethral instrumentation, or recent prostate surgery—defer by 6–8 weeks Journals.co.za.
    7. Repeat PSA if elevated but <10 ng/mL (“grey zone”) and DRE is normal. Abstain from ejaculation or cycling for ≥48 hours before repeat testing Journals.co.za.
    8. Use free/total PSA ratio for added specificity when total PSA is in the grey zone:
      • ≤10% ratio = >80% cancer probability.
      • ≥25% ratio = <10% cancer probability Journals.co.za.
    9. Adjust PSA level for men on 5-alpha-reductase inhibitors (finasteride or dutasteride): multiply PSA by 2 Journals.co.za.
    10. Do not prescribe antibiotics or alpha-blockers to lower PSA in asymptomatic men without infection Journals.co.za.
    11. Refer to a urologist when PSA remains persistently elevated (age-adjusted) or DRE is abnormal. In resource‐limited settings, very high PSA (e.g., >50 ng/mL) may suggest metastatic disease and prompt treatment even without biopsy Journals.co.za.

    Summary Table:

    Group / SituationGuideline
    Asymptomatic, informed, life > 10 yrsOffer PSA screening
    Age > 70 or life < 10 yrsDo not screen generally
    High-risk (Black, family history)Start from age 45
    Genetic mutation carriersStart from age 40 (or 10 yrs younger than young relative)
    Elevated PSA (<10 ng/mL)Repeat test after abstinence; consider free/total ratio
    On 5-ARI therapyAdjust PSA by doubling
    Suspicious results / high PSARefer to urologist; possible immediate treatment

    Additional Context: Prostate Screening Practices in South Africa

    Beyond formal guidelines, local health authorities and organizations highlight early detection and awareness:

    • Western Cape Health Department encourages annual screening for men aged 50+, especially with family history, aligning with the National Integrated Men’s Health Strategy 2020–2025 Western Cape Government.
    • The Prostate Cancer Foundation of South Africa advises:
      • All men over 45 get screened annually.
      • High-risk men (Black or family history) start at age 40 yeswecare.co.za.
    • Community efforts like workshops and PSA drives (e.g., outreach by The Urology Hospital in Pretoria) are happening during Men’s Health Month, emphasizing early screening, particularly for men 45+ with family history urology.co.za.

    Your Action Plan (Johannesburg Context)

    1. If you or someone you know is considering prostate screening:
      • Have an informed discussion with a healthcare provider about the risks and benefits.
      • If asymptomatic, consider PSA testing in line with age and risk profile.
      • Proceed with the PSA test alone unless DRE is clinically indicated.
      • Interpret results appropriately:
        • If PSA is “grey zone” (e.g., 4–10 ng/mL), consider repetition and free/total PSA evaluation.
        • Adjust PSA if the person is on finasteride or dutasteride.
    2. Encourage awareness:
      • Share with families and communities, especially Black men, about earlier and regular screening given higher local risk.
      • Support community health efforts like workshops or screenings during awareness months.
    3. Engage your healthcare provider:
      • Use shared decision-making tools.
      • Personalized screening intervals based on prostate risk factors and baseline PSA levels.

    Let me know if you’d like to explore:

    • Specific Johannesburg-based screening programs or clinics offering PSA testing.
    • Tools or pamphlets for patient education on prostate health.
    • How to facilitate informed decision-making in clinics or community settings.

    Happy to help further!

  • Neftaly Perinatal Mental Health Screening

    Neftaly Perinatal Mental Health Screening

    ???? Who Should Be Screened?

    • All pregnant individuals (ideally once per trimester)
    • All postpartum individuals (especially within 6–12 weeks after delivery)
    • Anyone with a history of mental illness, trauma, substance use, or psychosocial stressors

    ????️ Screening Tools Used in Neftaly’s Approach

    Neftaly likely uses evidence-based tools recommended by global mental health and maternal care guidelines:

    Screening ToolDescriptionWhen Used
    EPDS (Edinburgh Postnatal Depression Scale)10-question self-report tool for depression & anxietyAntenatally and postnatally
    PHQ-9 (Patient Health Questionnaire)Assesses severity of depressionThroughout perinatal period
    GAD-7 (General
  • Neftaly Neonatal Jaundice Screening

    Neftaly Neonatal Jaundice Screening

    Neftaly Neonatal Jaundice Screening

    1. Introduction

    Neonatal jaundice, characterized by yellowing of the skin and eyes due to elevated bilirubin levels, is a common condition affecting newborns. While often benign, severe jaundice can lead to serious complications like kernicterus if not detected and managed promptly.

    Neftaly’s Neonatal Jaundice Screening guidelines aim to support early identification, monitoring, and timely intervention to prevent morbidity and mortality associated with neonatal jaundice.

    2. Objectives

    • Promote early recognition of jaundice in newborns
    • Facilitate standardized screening protocols for timely diagnosis
    • Guide appropriate management and referral pathways
    • Reduce adverse outcomes from untreated hyperbilirubinemia

    3. Risk Factors

    Risk FactorDescription
    Prematurity (less than 37 weeks)Immature liver function affecting bilirubin metabolism
    Exclusive breastfeeding difficultiesPoor feeding can increase jaundice risk
    Hemolytic disease (e.g., blood group incompatibility)Accelerated breakdown of red blood cells
    Family history of neonatal jaundiceGenetic predisposition
    Bruising or cephalohematoma at birthIncreased bilirubin production
    InfectionsCan impair bilirubin clearance

    4. Screening Methods

    4.1 Visual Assessment

    • Inspect skin and sclera under natural light
    • Use Kramer’s scale to estimate jaundice progression from head to feet
    • Note that visual assessment is less reliable in dark-skinned infants

    4.2 Transcutaneous Bilirubinometry (TcB)

    • Non-invasive device measuring bilirubin through the skin
    • Useful for quick screening, especially in well-resourced settings

    4.3 Serum Bilirubin Testing

    • Confirmatory test measuring total serum bilirubin (TSB) levels
    • Indicated when jaundice is visible or risk factors present
    • Guides treatment decisions based on bilirubin thresholds

    5. Timing of Screening

    • First assessment within 24 hours of birth
    • Repeat screening between 48 to 72 hours when physiological jaundice typically peaks
    • More frequent monitoring for at-risk neonates or those with rising bilirubin

    6. Management and Referral

    • Mild jaundice: Encourage frequent feeding to promote bilirubin excretion
    • Moderate to severe jaundice: Consider phototherapy based on TSB levels and clinical condition
    • Critical levels or signs of encephalopathy: Urgent referral for intensive care and possible exchange transfusion

    7. Prevention

    • Promote early and exclusive breastfeeding
    • Educate caregivers on recognizing jaundice and feeding difficulties
    • Ensure clean delivery practices to reduce infection risk
    • Monitor at-risk infants closely during the first week of life

    8. Challenges and Solutions

    ChallengeNeftaly Strategy
    Limited access to bilirubin testingUse clinical risk assessment and TcB devices where available
    Inconsistent follow-upEstablish community health worker follow-up visits
    Caregiver awareness gapsConduct education sessions on jaundice warning signs
    Resource constraints for phototherapyPrioritize early detection and refer severe cases promptly

    9. Conclusion

    Timely and effective neonatal jaundice screening is essential to prevent serious complications. Neftaly supports healthcare providers with practical guidelines and tools to enhance early detection and management of neonatal jaundice, improving newborn health outcomes.

    For screening protocols, training materials, and technical support, contact Neftaly Maternal and Child Health Services.

  • Neftaly Hepatitis C Screening and Management

    Neftaly Hepatitis C Screening and Management

  • Neftaly Neonatal Screening and Follow-Up

    Neftaly Neonatal Screening and Follow-Up

    Neftaly Neonatal Screening and Follow-Up

    Ensuring Healthy Beginnings with Early Detection and Care

    At Neftaly, we are dedicated to supporting newborn health through timely and comprehensive neonatal screening and follow-up services. Early identification of potential health issues allows for prompt intervention, improving outcomes and providing families with peace of mind as their child grows.

    Our Mission

    To detect, diagnose, and manage newborn health conditions early—ensuring every child has the best chance for a healthy start and optimal development.

    What Is Neonatal Screening?

    Neonatal screening involves a series of tests performed shortly after birth to identify babies who may have certain genetic, metabolic, hormonal, or functional conditions that are not apparent at birth but can cause serious health problems if left untreated.

    Key Screenings Provided by Neftaly

    • Newborn Metabolic Screening: Detects rare but serious conditions such as phenylketonuria (PKU), congenital hypothyroidism, and cystic fibrosis.
    • Hearing Screening: Early identification of hearing impairments to support timely intervention and language development.
    • Congenital Heart Disease Screening: Pulse oximetry testing to detect critical heart defects.
    • Jaundice Monitoring: Assessment and follow-up for hyperbilirubinemia.
    • Vision Screening: Early checks for congenital eye abnormalities.
    • Other Specialized Screenings: Based on family history or regional protocols.

    Why Neonatal Screening Matters

    • Early Diagnosis: Allows for timely treatment to prevent complications.
    • Improved Developmental Outcomes: Early intervention supports better growth, cognition, and quality of life.
    • Informed Family Planning: Provides parents with essential health information.
    • Cost-Effective Care: Prevents costly long-term disabilities and hospitalizations.

    Neftaly’s Comprehensive Follow-Up Program

    Screening is only the first step. Neftaly ensures continuous care through:

    • Timely Communication of Results: Clear explanation of findings and implications for families.
    • Referral to Specialists: Access to pediatricians, audiologists, endocrinologists, genetic counselors, or cardiologists as needed.
    • Regular Monitoring: Scheduled check-ups to track growth, development, and treatment effectiveness.
    • Family Education and Support: Guidance on managing conditions, therapies, nutrition, and developmental milestones.
    • Coordination of Care: Integrated support across healthcare providers and community resources.

    Our Commitment to Families

    • Respectful, culturally sensitive care tailored to each family’s needs.
    • Transparent, compassionate communication every step of the way.
    • Empowerment through education and shared decision-making.
    • Accessibility of services in hospital, outpatient, and home settings.

    Why Choose Neftaly?

    • Experienced neonatal and pediatric healthcare professionals
    • State-of-the-art screening technologies and protocols
    • Comprehensive care pathways from screening to follow-up
    • Focus on early intervention and family-centered care
    • Commitment to continuous quality improvement and innovation

    Give Your Newborn the Best Start

    Early screening saves lives and shapes healthy futures. With Neftaly Neonatal Screening and Follow-Up, you can trust that your baby is receiving the vigilant care and expert attention needed to thrive.